nach oben

Erschienen in:

20.09.2021 | Conference Reports and Expert Panel

Critically ill cancer patient’s resuscitation: a Belgian/French societies’ consensus conference

verfasst von: Anne-Pascale Meert, Sebastian Wittnebel, Stéphane Holbrechts, Anne-Claire Toffart, Jean-Jacques Lafitte, Michael Piagnerelli, France Lemaitre, Olivier Peyrony, Laurent Calvel, Jean Lemaitre, Emmanuel Canet, Alexandre Demoule, Michael Darmon, Jean-Paul Sculier, Louis Voigt, Virginie Lemiale, Frédéric Pène, David Schnell, Etienne Lengline, Thierry Berghmans, Laurence Fiévet, Christiane Jungels, Xiaoxiao Wang, Ionela Bold, Aureliano Pistone, Adriano Salaroli, Bogdan Grigoriu, Dominique Benoit, on behalf of the Critically ill cancer patients consensus conference group

Erschienen in: Intensive Care Medicine | Ausgabe 10/2021

Einloggen, um Zugang zu erhalten

Abstract

To respond to the legitimate questions raised by the application of invasive methods of monitoring and life-support techniques in cancer patients admitted in the ICU, the European Lung Cancer Working Party and the Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique, set up a consensus conference. The methodology involved a systematic literature review, experts’ opinion and a final consensus conference about nine predefined questions

1. Which triage criteria, in terms of complications and considering the underlying neoplastic disease and possible therapeutic limitations, should be used to guide admission of cancer patient to intensive care units?

2. Which ventilatory support [High Flow Oxygenation, Non-invasive Ventilation (NIV), Invasive Mechanical Ventilation (IMV), Extra-Corporeal Membrane Oxygenation (ECMO)] should be used, for which complications and in which environment?

3. Which support should be used for extra-renal purification, in which conditions and environment?

4. Which haemodynamic support should be used, for which complications, and in which environment?

5. Which benefit of cardiopulmonary resuscitation in cancer patients and for which complications?

6. Which intensive monitoring in the context of oncologic treatment (surgery, anti-cancer treatment …)?

7. What specific considerations should be taken into account in the intensive care unit?

8. Based on which criteria, in terms of benefit and complications and taking into account the neoplastic disease, patients hospitalized in an intensive care unit (or equivalent) should receive cellular elements derived from the blood (red blood cells, white blood cells and platelets)?

9. Which training is required for critical care doctors in charge of cancer patients?

Nur mit Berechtigung zugänglich

Sant M, Minicozzi P, Mounier M, Anderson LA, Brenner H, Holleczek B, Marcos-Gragera R, Maynadie M, Monnereau A, Osca-Gelis G, Visser O, De Angelis R, E.-W. Group (2014) Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. Lancet Oncol 15(9):931–942PubMedCrossRef

Durocher A, Carpentier F, Dosquet P (1998) A methodology for consensus conferences. Societe Royale Belge de Gastro-enterologie, Acta Gastroenterol Belg 61(4):416–421PubMed

Shimabukuro-Vornhagen A, Boll B, Kochanek M, Azoulay E, von Bergwelt-Baildon MS (2016) Critical care of patients with cancer. CA Cancer J Clin 66(6):496–517PubMedCrossRef

Azoulay E, Mokart D, Pene F, Lambert J, Kouatchet A, Mayaux J, Vincent F, Nyunga M, Bruneel F, Laisne LM, Rabbat A, Lebert C, Perez P, Chaize M, Renault A, Meert AP, Benoit D, Hamidfar R, Jourdain M, Darmon M, Schlemmer B, Chevret S, Lemiale V (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium—a groupe de recherche respiratoire en reanimation onco-hematologique study. J Clin Oncol 31(22):2810–2818PubMedCrossRef

Gruson D, Vargas F, Hilbert G, Bui N, Maillot T, Mayet T, Pillet O, Chene G, Gbikpi-Benissan G (2004) Predictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia. Intensive Care Med 30(5):965–971PubMedCrossRef

Lengline E, Raffoux E, Lemiale V, Darmon M, Canet E, Boissel N, Schlemmer B, Dombret H, Azoulay E (2012) Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure. Leuk Lymphoma 53(7):1352–1359PubMedCrossRef

Mokart D, Lambert J, Schnell D, Fouche L, Rabbat A, Kouatchet A, Lemiale V, Vincent F, Lengline E, Bruneel F, Pene F, Chevret S, Azoulay E (2013) Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure. Leuk Lymphoma 54(8):1724–1729PubMedCrossRef

Azoulay E, Lemiale V, Mokart D, Pene F, Kouatchet A, Perez P, Vincent F, Mayaux J, Benoit D, Bruneel F, Meert AP, Nyunga M, Rabbat A, Darmon M (2014) Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med 40(8):1106–1114PubMedCrossRef

Zuber B, Tran TC, Aegerter P, Grimaldi D, Charpentier J, Guidet B, Mira JP, Pene F, Network CU-R (2012) Impact of case volume on survival of septic shock in patients with malignancies. Crit Care Med 40(1):55–62PubMedCrossRef

10.

Massion PB, Dive AM, Doyen C, Bulpa P, Jamart J, Bosly A, Installe E (2002) Prognosis of hematologic malignancies does not predict intensive care unit mortality. Crit Care Med 30(10):2260–2270PubMedCrossRef

11.

Soares M, Salluh JIF, Torres VBL, Leal JVR, Spector N (2008) Short- and long-term outcomes of critically ill patients with cancer and prolonged ICU length of stay. Chest 134(3):520–526PubMedCrossRef

12.

McGrath S, Chatterjee F, Whiteley C, Ostermann M (2010) ICU and 6-month outcome of oncology patients in the intensive care unit. QJM 103(6):397-403PubMedCrossRef

13.

Soares M, Bozza FA, Azevedo LC, Silva UV, Correa TD, Colombari F, Torelly AP, Varaschin P, Viana WN, Knibel MF, Damasceno M, Espinoza R, Ferez M, Silveira JG, Lobo SA, Moraes AP, Lima RA, de Carvalho AG, do Brasil PE, Kahn JM, Angus DC, Salluh JI (2016) Effects of organizational characteristics on outcomes and resource use in patients with cancer admitted to intensive care units. J Clin Oncol 34(27):3315–3324PubMedCrossRef

14.

Darmon M, Bourmaud A, Georges Q, Soares M, Jeon K, Oeyen S, Rhee CK, Gruber P, Ostermann M, Hill QA, Depuydt P, Ferra C, Toffart AC, Schellongowski P, Muller A, Lemiale V, Mokart D, Azoulay E (2019) Changes in critically ill cancer patients’ short-term outcome over the last decades: results of systematic review with meta-analysis on individual data. Intensive Care Med 45(7):977–987PubMedCrossRef

15.

Azoulay E, Pene F, Darmon M, Lengline E, Benoit D, Soares M, Vincent F, Bruneel F, Perez P, Lemiale V, Mokart D, O.-H. Groupe de Recherche Respiratoire en Reanimation (2015) Managing critically ill hematology patients: time to think differently. Blood Rev 29(6):359–367PubMedCrossRef

16.

Soares M, Salluh JI, Spector N, Rocco JR (2005) Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for > 24 hrs. Crit Care Med 33(3):520–526PubMedCrossRef

17.

Shrime MG, Ferket BS, Scott DJ, Lee J, Barragan-Bradford D, Pollard T, Arabi YM, Al-Dorzi HM, Baron RM, Hunink MG, Celi LA, Lai PS (2016) Time-limited trials of intensive care for critically ill patients with cancer: how long is long enough? JAMA Oncol 2(1):76–83PubMedPubMedCentralCrossRef

18.

Lengline E, Chevret S, Moreau AS, Pene F, Blot F, Bourhis JH, Buzyn A, Schlemmer B, Socie G, Azoulay E (2015) Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 50(6):840–845PubMedCrossRef

19.

Lueck C, Stadler M, Koenecke C, Hoeper MM, Dammann E, Schneider A, Kielstein JT, Ganser A, Eder M, Beutel G (2018) Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients. Intensive Care Med 44(9):1483–1492PubMedCrossRef

20.

Ahmedzai SH, Laude E, Robertson A, Troy G, Vora V (2004) A double-blind, randomised, controlled Phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion. Br J Cancer 90(2):366–371PubMedPubMedCentralCrossRef

21.

Booth S, Kelly MJ, Cox NP, Adams L, Guz A (1996) Does oxygen help dyspnea in patients with cancer? Am J Respir Crit Care Med 153(5):1515–1518PubMedCrossRef

22.

Bruera E, Sweeney C, Willey J, Palmer JL, Strasser F, Morice RC, Pisters K (2003) A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea. Palliat Med 17(8):659–663PubMed

23.

Philip J, Gold M, Milner A, Di Iulio J, Miller B, Spruyt O (2006) A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer. J Pain Symptom Manag 32(6):541–550CrossRef

24.

Uronis HE, Currow DC, McCrory DC, Samsa GP, Abernethy AP (2008) Oxygen for relief of dyspnoea in mildly- or non-hypoxaemic patients with cancer: a systematic review and meta-analysis. Br J Cancer 98(2):294–299PubMedPubMedCentralCrossRef

25.

Azoulay E, Lemiale V, Mokart D, Nseir S, Argaud L, Pene F, Kontar L, Bruneel F, Klouche K, Barbier F, Reignier J, Berrahil-Meksen L, Louis G, Constantin JM, Mayaux J, Wallet F, Kouatchet A, Peigne V, Theodose I, Perez P, Girault C, Jaber S, Oziel J, Nyunga M, Terzi N, Bouadma L, Lebert C, Lautrette A, Bige N, Raphalen JH, Papazian L, Darmon M, Chevret S, Demoule A (2018) Effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with acute respiratory failure: the HIGH randomized clinical trial. JAMA 320(20):2099–2107PubMedPubMedCentralCrossRef

26.

Lemiale V, Mokart D, Mayaux J, Lambert J, Rabbat A, Demoule A, Azoulay E (2015) The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multicenter randomized trial. Crit Care 19:380PubMedPubMedCentralCrossRef

27.

Lemiale V, Resche-Rigon M, Mokart D, Pene F, Argaud L, Mayaux J, Guitton C, Rabbat A, Girault C, Kouatchet A, Vincent F, Bruneel F, Nyunga M, Seguin A, Klouche K, Colin G, Kontar L, Perez P, Meert AP, Benoit DD, Papazian L, Demoule A, Chevret S, Azoulay E (2017) High-flow nasal cannula oxygenation in immunocompromised patients with acute hypoxemic respiratory failure: a Groupe de Recherche Respiratoire en Reanimation Onco-Hematologique study. Crit Care Med 45(3):e274–e280PubMedCrossRef

28.

Frat JP, Ragot S, Girault C, Perbet S, Prat G, Boulain T, Demoule A, Ricard JD, Coudroy R, Robert R, Mercat A, Brochard L, Thille AW, R. network (2016) Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post-hoc analysis of a randomised trial. Lancet Respir Med 4(8):646–652PubMedCrossRef

29.

Dumas G, Chevret S, Lemiale V, Pene F, Demoule A, Mayaux J, Kouatchet A, Nyunga M, Perez P, Argaud L, Barbier F, Vincent F, Bruneel F, Klouche K, Kontar L, Moreau AS, Reignier J, Papazian L, Cohen Y, Mokart D, Azoulay E (2018) Oxygenation/non-invasive ventilation strategy and risk for intubation in immunocompromised patients with hypoxemic acute respiratory failure. Oncotarget 9(72):33682–33693PubMedPubMedCentralCrossRef

30.

Mokart D, Geay C, Chow-Chine L, Brun JP, Faucher M, Blache JL, Bisbal M, Sannini A (2015) High-flow oxygen therapy in cancer patients with acute respiratory failure. Intensive Care Med 41(11):2008–2010PubMedCrossRef

31.

Azoulay E, Pickkers P, Soares M, Perner A, Rello J, Bauer PR, van de Louw A, Hemelaar P, Lemiale V, Taccone FS, Loeches IM, Meyhoff TS, Salluh J, Schellongowski P, Rusinova K, Terzi N, Mehta S, Antonelli M, Kouatchet A, Barratt-Due A, Valkonen M, Landburg PP, Bruneel F, Bukan RB, Pene F, Metaxa V, Moreau AS, Souppart V, Burghi G, Girault C, Silva UVA, Montini L, Barbier F, Nielsen LB, Gaborit B, Mokart D, Chevret S, Efraim I, I.S.G. the Nine (2017) Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study. Intensive Care Med 43(12):1808–1819PubMedCrossRef

32.

Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M, Reiffers J, Cardinaud JP (2001) Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344(7):481–487PubMedCrossRef

33.

Lemiale V, Mokart D, Resche-Rigon M, Pene F, Mayaux J, Faucher E, Nyunga M, Girault C, Perez P, Guitton C, Ekpe K, Kouatchet A, Theodose I, Benoit D, Canet E, Barbier F, Rabbat A, Bruneel F, Vincent F, Klouche K, Loay K, Mariotte E, Bouadma L, Moreau AS, Seguin A, Meert AP, Reignier J, Papazian L, Mehzari I, Cohen Y, Schenck M, Hamidfar R, Darmon M, Demoule A, Chevret S, Azoulay E, d.O.-H. Groupe de Recherche en Reanimation Respiratoire du patient (2015) Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: a randomized clinical trial. JAMA 314(16):1711–1719PubMedCrossRef

34.

Meert AP, Berghmans T, Markiewicz E, Hardy M, Nayer N, Paesmans M, Sculier JP (2011) Invasive mechanical ventilation in cancer patients. Prior non invasive ventilation is a poor prognostic factor. J BUON 16(1):160–165PubMed

35.

Neuschwander A, Lemiale V, Darmon M, Pene F, Kouatchet A, Perez P, Vincent F, Mayaux J, Benoit D, Bruneel F, Meert AP, Nyunga M, Rabbat A, Mokart D, Azoulay E, A.G.d.R.e.R.R.e.O.-H. study (2017) Noninvasive ventilation during acute respiratory distress syndrome in patients with cancer: trends in use and outcome. J Crit Care 38:295–299PubMedCrossRef

36.

Rathi NK, Haque SA, Nates R, Kosturakis A, Wang H, Dong W, Feng L, Erfe RJ, Guajardo C, Withers L, Finch C, Price KJ, Nates JL (2017) Noninvasivepositive pressure ventilation vsinvasive mechanical ventilation as first-line therapy for acute hypoxemic respiratory failure in cancer patients. J Crit Care 39:56–61PubMedCrossRef

37.

Turkoglu M, Erdem GU, Suyani E, Sancar ME, Yalcin MM, Aygencel G, Aki Z, Sucak G (2013) Acute respiratory distress syndrome in patients with hematological malignancies. Hematology 18(3):123–130PubMedCrossRef

38.

Bauer PR, Chevret S, Yadav H, Mehta S, Pickkers P, Bukan RB, Rello J, van de Louw A, Klouche K, Meert AP, Martin-Loeches I, Marsh B, Crespi LS, Moreno-Gonzalez G, Buchtele N, Amrein K, Balik M, Antonelli M, Nyunga M, Barratt-Due A, Bergmans D, Spoelstra-de Man AME, Kuitunen A, Wallet F, Seguin A, Metaxa V, Lemiale V, Burghi G, Demoule A, Karvunidis T, Cotoia A, Klepstad P, Moller AM, Mokart D, Azoulay E, Efraim I, I.s.g. the Nine (2019) Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy. Eur Respir J 54(1):07CrossRef

39.

Schmidt M, Schellongowski P, Patroniti N, Taccone FS, Reis Miranda D, Reuter J, Prodanovic H, Pierrot M, Dorget A, Park S, Balik M, Demoule A, Crippa IA, Mercat A, Wohlfarth P, Sonneville R, Combes A (2018) Six-month outcome of immunocompromised patients with severe acute respiratory distress syndrome rescued by extracorporeal membrane oxygenation: an international multicenter retrospective study. Am J Respir Crit Care Med 197(10):1297–1307PubMedPubMedCentralCrossRef

40.

Gow KW, Lao OB, Leong T, Fortenberry JD (2010) Extracorporeal life support for adults with malignancy and respiratory or cardiac failure: the Extracorporeal Life Support experience. Am J Surg 199(5):669–675PubMedCrossRef

41.

Wohlfarth P, Ullrich R, Staudinger T, Bojic A, Robak O, Hermann A, Lubsczyk B, Worel N, Fuhrmann V, Schoder M, Funovics M, Rabitsch W, Knoebl P, Laczika K, Locker GJ, Sperr WR, Schellongowski P, N. Arbeitsgruppe fur hamato-onkologische Intensivmedizin der Osterreichischen Gesellschaft fur Internistische und Allgemeine Intensivmedizin und (2014) Extracorporeal membrane oxygenation in adult patients with hematologic malignancies and severe acute respiratory failure. Crit Care 18(1):R20PubMedPubMedCentralCrossRef

42.

Kang HS, Rhee CK, Lee HY, Kim YK, Kwon SS, Kim SC, Lee JW (2015) Clinical outcomes of extracorporeal membrane oxygenation support in patients with hematologic malignancies. Korean J Intern Med 30(4):478–488PubMedPubMedCentralCrossRef

43.

Wu MY, Wu TI, Tseng YH, Shen WC, Chang YS, Huang CC, Lin PJ (2015) The feasibility of venovenous extracorporeal life support to treat acute respiratory failure in adult cancer patients. Medicine (Baltimore) 94(21):e893CrossRef

44.

Wohlfarth P, Beutel G, Lebiedz P, Stemmler HJ, Staudinger T, Schmidt M, Kochanek M, Liebregts T, Taccone FS, Azoulay E, Demoule A, Kluge S, Svalebjorg M, Lueck C, Tischer J, Combes A, Boll B, Rabitsch W, Schellongowski P, H. Intensive Care in, P. Oncologic, N. Caring for Critically Ill Immunocompromised Patients Multinational (2017) Characteristics and outcome of patients after allogeneic hematopoietic stem cell transplantation treated with extracorporeal membrane oxygenation for acute respiratory distress syndrome. Crit Care Med 45(5):e500–e507PubMedCrossRef

45.

Baumgartner G, Major A, Merrin CE (1976) Hemodialysis in patients with carcinoma. J Surg Oncol 8(4):339–344PubMedCrossRef

46.

Beckley S, Wajsman LZ, Pontes JE, Major A, Murphy GP (1982) Intermittent hemodialysis therapy in the cancer patient. J Surg Oncol 21(4):261–263PubMedCrossRef

47.

Benoit DD, Hoste EA, Depuydt PO, Offner FC, Lameire NH, Vandewoude KH, Dhondt AW, Noens LA, Decruyenaere JM (2005) Outcome in critically ill medical patients treated with renal replacement therapy for acute renal failure: comparison between patients with and those without haematological malignancies. Nephrol Dial Transplant 20(3):552–558PubMedCrossRef

48.

Berghmans T, Meert AP, Markiewicz E, Sculier JP (2004) Continuous venovenous haemofiltration in cancer patients with renal failure: a single-centre experience. Support Care Cancer 12(5):306–311PubMedCrossRef

49.

Bridoux F, Carron PL, Pegourie B, Alamartine E, Augeul-Meunier K, Karras A, Joly B, Peraldi MN, Arnulf B, Vigneau C, Lamy T, Wynckel A, Kolb B, Royer B, Rabot N, Benboubker L, Combe C, Jaccard A, Moulin B, Knebelmann B, Chevret S, Fermand JP, M.S. Group (2017) Effect of high-cutoff hemodialysis vs conventional hemodialysis on hemodialysis independence among patients with myeloma cast nephropathy: a randomized clinical trial. JAMA 318(21):2099–2110PubMedPubMedCentralCrossRef

50.

Canet E, Zafrani L, Lambert J, Thieblemont C, Galicier L, Schnell D, Raffoux E, Lengline E, Chevret S, Darmon M, Azoulay E (2013) Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival. PLoS ONE 8(2):e55870PubMedPubMedCentralCrossRef

51.

Cosio FG, Pence TV, Shapiro FL, Kjellstrand CM (1981) Severe renal failure in multiple myeloma. Clin Nephrol 15(4):206–210PubMed

52.

Darmon M, Thiery G, Ciroldi M, Porcher R, Schlemmer B, Azoulay E (2007) Should dialysis be offered to cancer patients with acute kidney injury? Intensive Care Med 33(5):765–772PubMedCrossRef

53.

Darmon M, Vincent F, Canet E, Mokart D, Pene F, Kouatchet A, Mayaux J, Nyunga M, Bruneel F, Rabbat A, Lebert C, Perez P, Renault A, Meert AP, Benoit D, Hamidfar R, Jourdain M, Schlemmer B, Chevret S, Lemiale V, Azoulay E (2015) Acute kidney injury in critically ill patients with haematological malignancies: results of a multicentre cohort study from the Groupe de Recherche en Reanimation Respiratoire en Onco-Hematologie. Nephrol Dial Transplant 30(12):2006–2013PubMedPubMedCentralCrossRef

54.

Fischler R, Meert AP, Sculier JP, Berghmans T (2016) Continuous renal replacement therapy for acute renal failure in patients with cancer: a well-tolerated adjunct treatment. Front Med (Lausanne) 3:33

55.

Flores FX, Brophy PD, Symons JM, Fortenberry JD, Chua AN, Alexander SR, Mahan JD, Bunchman TE, Blowey D, Somers MJ, Baum M, Hackbarth R, Chand D, McBryde K, Benfield M, Goldstein SL (2008) Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT Registry Group. Pediatr Nephrol 23(4):625–630PubMedCrossRef

56.

Garimella PS, Balakrishnan P, Ammakkanavar NR, Patel S, Patel A, Konstantinidis I, Annapureddy N, Nadkarni GN (2017) Impact of dialysis requirement on outcomes in tumor lysis syndrome. Nephrology 22(1):85–88PubMedCrossRef

57.

Gerth HU, Pohlen M, Gorlich D, Tholking G, Kropff M, Berdel WE, Pavenstadt H, Brand M, Kumpers P (2016) Impact of high-cut-off dialysis on renal recovery in dialysis-dependent multiple myeloma patients: results from a case-control study. PLoS ONE 11(5):e0154993PubMedPubMedCentralCrossRef

58.

Gilbert C, Vasu TS, Baram M (2013) Use of mechanical ventilation and renal replacement therapy in critically ill hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 19(2):321–324PubMedCrossRef

59.

Gruss E, Tomas JF, Bernis C, Rodriguez F, Traver JA, Fernandez-Ranada JM (1998) Acute renal failure in the allogeneic transplantation of hemopoietic progenitors. The clinical characteristics in a series of 92 patients. Med Clin (Barc) 111(20):774–775

60.

Heyne N, Denecke B, Guthoff M, Oehrlein K, Kanz L, Haring HU, Weisel KC (2012) Extracorporeal light chain elimination: high cut-off (HCO) hemodialysis parallel to chemotherapy allows for a high proportion of renal recovery in multiple myeloma patients with dialysis-dependent acute kidney injury. Ann Hematol 91(5):729–735PubMedCrossRef

61.

Hutchison CA, Bradwell AR, Cook M, Basnayake K, Basu S, Harding S, Hattersley J, Evans ND, Chappel MJ, Sampson P, Foggensteiner L, Adu D, Cockwell P (2009) Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin J Am Soc Nephrol 4(4):745–754PubMedPubMedCentralCrossRef

62.

Hutchison CA, Cockwell P, Reid S, Chandler K, Mead GP, Harrison J, Hattersley J, Evans ND, Chappell MJ, Cook M, Goehl H, Storr M, Bradwell AR (2007) Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in vitro and in vivo studies. J Am Soc Nephrol 18(3):886–895PubMedCrossRef

63.

Hutchison CA, Heyne N, Airia P, Schindler R, Zickler D, Cook M, Cockwell P, Grima D (2012) Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis. Nephrol Dial Transplant 27(10):3823–3828PubMedCrossRef

64.

Joseph A, Harel S, Venot M, Valade S, Mariotte E, Pichereau C, Chermak A, Zafrani L, Azoulay E, Canet E (2018) Renal recovery after severe acute kidney injury in critically ill myeloma patients: a retrospective study. Clin Kidney J 11(1):20–25PubMedCrossRef

65.

Katagiri D, Hagiwara S, Minami E, Katsuma A, Masumoto S, Hoshino T, Inoue T, Shibata M, Tada M, Nakamura T, Shimbo T, Hinoshita F (2011) Factors associated with recovery of renal function in patients with multiple myeloma who were treated with hemodialysis. Nephron 117(1):c28-32PubMed

66.

Khalafallah AA, Loi SW, Love S, Mohamed M, Mace R, Khalil R, Girgs M, Raj R, Mathew M (2013) Early application of high cut-off haemodialysis for de-novo myeloma nephropathy is associated with long-term dialysis-independency and renal recovery. Mediterr J Hematol Infect Dis 5(1):e2013007PubMedPubMedCentralCrossRef

67.

Lane PH, Mauer SM, Blazar BR, Ramsay NK, Kashtan CE (1994) Outcome of dialysis for acute renal failure in pediatric bone marrow transplant patients. Bone Marrow Transplant 13(5):613–617PubMed

68.

Lanore JJ, Brunet F, Pochard F, Bellivier F, Dhainaut JF, Vaxelaire JF, Giraud T, Dreyfus F, Dreyfuss D, Chiche JD et al (1991) Hemodialysis for acute renal failure in patients with hematologic malignancies. Crit Care Med 19(3):346–351PubMedCrossRef

69.

Letourneau I, Dorval M, Belanger R, Legare M, Fortier L, Leblanc M (2002) Acute renal failure in bone marrow transplant patients admitted to the intensive care unit. Nephron 90(4):408–412PubMedCrossRef

70.

Maccariello E, Valente C, Nogueira L, Bonomo H Jr, Ismael M, Machado JE, Baldotto F, Godinho M, Rocha E, Soares M (2011) Outcomes of cancer and non-cancer patients with acute kidney injury and need of renal replacement therapy admitted to general intensive care units. Nephrol Dial Transplant 26(2):537–543PubMedCrossRef

71.

Park MR, Jeon K, Song JU, Lim SY, Park SY, Lee JE, Huh W, Kim K, Kim WS, Jung CW, Suh GY (2011) Outcomes in critically ill patients with hematologic malignancies who received renal replacement therapy for acute kidney injury in an intensive care unit. J Crit Care 26(1):107.e1–6CrossRef

72.

Rodrigues L, Neves M, Sa H, Gomes H, Pratas J, Campos M (2014) Severe acute kidney injury and multiple myeloma: evaluation of kidney and patient prognostic factors. Eur J Intern Med 25(7):652–656PubMedCrossRef

73.

Rousseau-Gagnon M, Agharazii M, De Serres SA, Desmeules S (2015) Effectiveness of haemodiafiltration with heat sterilized high-flux polyphenylene HF dialyzer in reducing free light chains in patients with myeloma cast nephropathy. PLoS ONE 10(10):e0140463PubMedPubMedCentralCrossRef

74.

Saez MI, Camarero V, Rosales A, Hijazi B, Izquierdo MJ, Labrador J, Alvarez R, Hermida J, Mercado V, Badia MD, de Toro R, Gonzalez B, Abaigar P (2017) Acute renal failure in patients with myeloma: experience with extended high cut-off hemodialysis. Nefrologia 37(4):429–431PubMedCrossRef

75.

Salahudeen AK, Kumar V, Madan N, Xiao L, Lahoti A, Samuels J, Nates J, Price K (2009) Sustained low efficiency dialysis in the continuous mode (C-SLED): dialysis efficacy, clinical outcomes, and survival predictors in critically ill cancer patients. Clin J Am Soc Nephrol 4(8):1338–1346PubMedPubMedCentralCrossRef

76.

Sens F, Chaintreuil D, Jolivot A, Guebre-Egziabher F, Robinson P, Karlin L, Bridoux F, Juillard L (2017) Effectiveness of IHD with adsorptive PMMA membrane in myeloma cast nephropathy: a cohort study. Am J Nephrol 46(5):355–363PubMedCrossRef

77.

Smoyer WE, McAdams C, Kaplan BS, Sherbotie JR (1995) Determinants of survival in pediatric continuous hemofiltration. J Am Soc Nephrol 6(5):1401–1409PubMedCrossRef

78.

Soares M, Lobo SM, Torelly AP, Mello PV, Silva U, Teles JM, Silva E, Caruso P, Friedman G, Souza PC, Rea-Neto A, Vianna AO, Azevedo JR, Vale E, Rezegue L, Godoy M, Maia MO, Salluh JI, I. Rede Brasileira de Pesquisa em Terapia (2010) Outcomes of cancer patients admitted to Brazilian intensive care units with severe acute kidney injury. Rev Bras Ter Intensiva 22(3):236–244PubMedCrossRef

79.

Soares M, Salluh JI, Carvalho MS, Darmon M, Rocco JR, Spector N (2006) Prognosis of critically ill patients with cancer and acute renal dysfunction. J Clin Oncol 24(24):4003–4010PubMedCrossRef

80.

Zucchelli P, Pasquali S, Cagnoli L, Ferrari G (1988) Controlled plasma exchange trial in acute renal failure due to multiple myeloma. Kidney Int 33(6):1175–1180PubMedCrossRef

81.

Clark WF, Stewart AK, Rock GA, Sternbach M, Sutton DM, Barrett BJ, Heidenheim AP, Garg AX, Churchill DN, G. Canadian Apheresis (2005) Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial. Ann Intern Med 143(11):777–784PubMedCrossRef

82.

Hutchison CA, Cockwell P, Moroz V, Bradwell AR, Fifer L, Gillmore JD, Jesky MD, Storr M, Wessels J, Winearls CG, Weisel K, Heyne N, Cook M (2019) High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial. Lancet Haematol 6(4):e217–e228PubMedCrossRef

83.

Johnson WJ, Kyle RA, Pineda AA, O’Brien PC, Holley KE (1990) Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy. Arch Intern Med 150(4):863–869PubMedCrossRef

84.

Munker R, Hill U, Jehn U, Kolb HJ, Schalhorn A (1998) Renal complications in acute leukemias. Haematologica 83(5):416–421PubMed

85.

Darmon M, Guichard I, Vincent F, Schlemmer B, Azoulay E (2010) Prognostic significance of acute renal injury in acute tumor lysis syndrome. Leuk Lymphoma 51(2):221–227PubMedCrossRef

86.

Darmon M, Vincent F, Camous L, Canet E, Bonmati C, Braun T, Caillot D, Cornillon J, Dimicoli S, Etienne A, Galicier L, Garnier A, Girault S, Hunault-Berger M, Marolleau JP, Moreau P, Raffoux E, Recher C, Thiebaud A, Thieblemont C, Azoulay E, O.-H. Groupe de Recherche en Reanimation Respiratoire et (2013) Tumour lysis syndrome and acute kidney injury in high-risk haematology patients in the rasburicase era. A prospective multicentre study from the Groupe de Recherche en Reanimation Respiratoire et Onco-Hematologique. Br J Haematol 162(4):489–497PubMedCrossRef

87.

Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Intensive Care Med 43(3):304–377CrossRefPubMed

88.

Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer C, Jaeschke R, Mebazaa A, Pinsky MR, Teboul JL, Vincent JL, Rhodes A (2014) Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine. Intensive Care Med 40(12):1795–1815PubMedPubMedCentralCrossRef

89.

Reisfield GM, Wallace SK, Munsell MF, Webb FJ, Alvarez ER, Wilson GR (2006) Survival in cancer patients undergoing in-hospital cardiopulmonary resuscitation: a meta-analysis. Resuscitation 71(2):152–160PubMedCrossRef

90.

Winther-Jensen M, Kjaergaard J, Hassager C, Kober L, Lippert F, Soholm H (2018) Cancer is not associated with higher short or long-term mortality after successful resuscitation from out-of-hospital cardiac arrest when adjusting for prognostic factors. Eur Heart J Acute Cardiovasc Care 9(4_suppl):S184–S192PubMedCrossRef

91.

Martin C, Auboyer C, Boisson M, Dupont H, Gauzit R, Kitzis M, Leone M, Lepape A, Mimoz O, Montravers P, Pourriat JL, Steering committee of the French Society of, g (2019) Intensive Care Medicine responsible for the establishment of the, antibioprophylaxis in surgery and interventional medicine (adult patients): update 2017. Anaesth Crit Care Pain Med 38(5):549–562PubMedCrossRef

92.

Ricard JD, Salomon L, Boyer A, Thiery G, Meybeck A, Roy C, Pasquet B, Le Miere E, Dreyfuss D (2013) Central or peripheral catheters for initial venous access of ICU patients: a randomized controlled trial. Crit Care Med 41(9):2108–2115PubMedCrossRef

93.

O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad AG II, Randolph ME, Rupp SS, C. Healthcare Infection Control Practices Advisory (2011) Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52(9):e162–e193PubMedPubMedCentralCrossRef

94.

Taxbro K, Hammarskjold F, Thelin B, Lewin F, Hagman H, Hanberger H, Berg S (2019) Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial. Br J Anaesth 122(6):734–741PubMedCrossRef

95.

Lai NM, Chaiyakunapruk N, Lai NA, O’Riordan E, Pau WS, Saint S (2016) Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Database Syst Rev 3:CD007878PubMed

96.

Grudzen CR, Richardson LD, Johnson PN, Hu M, Wang B, Ortiz JM, Kistler EA, Chen A, Morrison RS (2016) Emergency department-initiated palliative care in advanced cancer: a randomized clinical trial. JAMA Oncol 2(5):591–598PubMedCrossRef

97.

Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733–742CrossRefPubMed

98.

Brumley R, Enguidanos S, Jamison P, Seitz R, Morgenstern N, Saito S, McIlwane J, Hillary K, Gonzalez J (2007) Increased satisfaction with care and lower costs: results of a randomized trial of in-home palliative care. J Am Geriatr Soc 55(7):993–1000PubMedCrossRef

99.

Gade G, Venohr I, Conner D, McGrady K, Beane J, Richardson RH, Williams MP, Liberson M, Blum M, della Penna R (2008) Impact of an inpatient palliative care team: a randomized control trial. J Palliat Med 11(2):180–190PubMedCrossRef

100.

Pantilat SZ, O’Riordan DL, Dibble SL, Landefeld CS (2010) Hospital-based palliative medicine consultation: a randomized controlled trial. Arch Intern Med 170(22):2038–2040PubMedCrossRef

101.

Rabow MW, Dibble SL, Pantilat SZ, McPhee SJ (2004) The comprehensive care team: a controlled trial of outpatient palliative medicine consultation. Arch Intern Med 164(1):83–91CrossRefPubMed

102.

Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J, Hull JG, Li Z, Tosteson TD, Byock IR, Ahles TA (2009) Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA 302(7):741–749PubMedPubMedCentralCrossRef

103.

Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z, Dionne-Odom JN, Frost J, Dragnev KH, Hegel MT, Azuero A, Ahles TA (2015) Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol 33(13):1438–1445PubMedPubMedCentralCrossRef

104.

Chen CH, Chen JS, Wen FH, Chang WC, Chou WC, Hsieh CH, Hou MM, Tang ST (2019) An Individualized, interactive intervention promotes terminally ill cancer patients’ prognostic awareness and reduces cardiopulmonary resuscitation received in the last month of life: secondary analysis of a randomized clinical trial. J Pain Symptom Manag 57(4):705–714CrossRef

105.

Kaasa S, Loge JH, Aapro M, Albreht T, Anderson R, Bruera E, Brunelli C, Caraceni A, Cervantes A, Currow DC, Deliens L, Fallon M, Gomez-Batiste X, Grotmol KS, Hannon B, Haugen DF, Higginson IJ, Hjermstad MJ, Hui D, Jordan K, Kurita GP, Larkin PJ, Miccinesi G, Nauck F, Pribakovic R, Rodin G, Sjogren P, Stone P, Zimmermann C, Lundeby T (2018) Integration of oncology and palliative care: a Lancet Oncology Commission. Lancet Oncol 19(11):e588–e653PubMedCrossRef

106.

Vanbutsele G, Pardon K, Van Belle S, Surmont V, De Laat M, Colman R, Eecloo K, Cocquyt V, Geboes K, Deliens L (2018) Effect of early and systematic integration of palliative care in patients with advanced cancer: a randomised controlled trial. Lancet Oncol 19(3):394–404PubMedCrossRef

107.

Estcourt LJ, Stanworth SJ, Hopewell S, Doree C, Trivella M, Massey E (2016) Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev 4:CD005339PubMed

108.

Price TH, Boeckh M, Harrison RW, McCullough J, Ness PM, Strauss RG, Nichols WG, Hamza TH, Cushing MM, King KE, Young JA, Williams E, McFarland J, Chakrabarty JH, Sloan SR, Friedman D, Parekh S, Sachais BS, Kiss JE, Assmann SF (2015) Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection. Blood 126(18):2153–2161PubMedPubMedCentralCrossRef

Titel: Critically ill cancer patient’s resuscitation: a Belgian/French societies’ consensus conference
verfasst von: Anne-Pascale Meert
Sebastian Wittnebel
Stéphane Holbrechts
Anne-Claire Toffart
Jean-Jacques Lafitte
Michael Piagnerelli
France Lemaitre
Olivier Peyrony
Laurent Calvel
Jean Lemaitre
Emmanuel Canet
Alexandre Demoule
Michael Darmon
Jean-Paul Sculier
Louis Voigt
Virginie Lemiale
Frédéric Pène
David Schnell
Etienne Lengline
Thierry Berghmans
Laurence Fiévet
Christiane Jungels
Xiaoxiao Wang
Ionela Bold
Aureliano Pistone
Adriano Salaroli
Bogdan Grigoriu
Dominique Benoit
on behalf of the Critically ill cancer patients consensus conference group
Publikationsdatum: 20.09.2021
Verlag: Springer Berlin Heidelberg
Erschienen in: Intensive Care Medicine / Ausgabe 10/2021
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-021-06508-w

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Springer Medizin

Critically ill cancer patient’s resuscitation: a Belgian/French societies’ consensus conference

Abstract

Neu im Fachgebiet AINS

Akuter Schwindel: Wann lohnt sich eine MRT?

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Update AINS

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2021

Preempting critical care services for patients with hematological malignancies

Role of total lung stress on the progression of early COVID-19 pneumonia

Ketamine-induced cholangiopathy in ARDS patients

How COVID-19 will change the management of other respiratory viral infections

Impact of different visiting policies on family satisfaction in two Spanish ICUs before and during COVID-19

Monocyte distribution width as a biomarker of resistance to corticosteroids in patients with sepsis: the MOCORSEP observational study

Neu im Fachgebiet AINS

Akuter Schwindel: Wann lohnt sich eine MRT?

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Hinter dieser Appendizitis steckte ein Erreger

Ärztliche Empathie hilft gegen Rückenschmerzen

Update AINS